Neurocrine Biosciences reported $182.8M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
ALKERMES ALKS:US 150.38M 5.32M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Amgen AMGN:US $ 1.33B 99M
Biogen BIIB:US $ 572.6M 62.3M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Cytokinetics CYTK:US $ 42.72M 9.65M
Dynavax Technologies DVAX:US $ 35.74M 4.27M
Enanta Pharmaceuticals ENTA:US $ 12.93M 2.45M
Exelixis EXEL:US $ 122.76M 19.9M
Gilead Sciences GILD:US $ 1.36B 274M
Halozyme Therapeutics HALO:US $ 57.48M 43.64M
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
Intra Cellular Therapies ITCI:US $ 100.32M 24.86M
IONIS PHARMACEUT IONS:US $ 33.8M 325K
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Pfizer PFE:US $ 3.2B 506M
Prothena PRTA:US 12.95M 1.12M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Repligen RGEN:US $ 54.65M 349K
Rigel Pharmaceuticals RIGL:US $ 26.98M 420K
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Teva Pharmaceutical TEVA:IT 849M 30M
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
Xoma XOMA:US $ 5.71M 594K
YTE INCY:US $ 253.28M 43.69M